You are here

Medical - global

Primary tabs

The medical working group is focused on issues that affect delivery of medical care to those in need

The medical working group seeks to address issues affecting delivery of medical care to those in need.

Members

Dr Ojia Adamolekun LadyCath mike kraft

Email address for group

medical-global@m.resiliencesystem.org

Antidepressant users may be less likely to test positive for COVID-19--study

New research published in BMC Medicine suggests that using antidepressants (ADs), especially selective serotonin reuptake inhibitors (SSRIs), could help prevent COVID-19 infection.

...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

HEALTH CARE SUMMIT, JUNE 22, 8:30 AM ET

 

 

 

ATTEND THE HILL'S   HEALTH CARE SUMMIT,  THURSDAY JUNE 22, 8:30 AM  ET

National Press Club Ballroom, 529 14th St. NW, 13th Floor, Washington, DC 20045  

SPEAKERS: 

  • Dr. Jerome Adams, former Surgeon General
  • Dr. Anthony Fauci, former Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  • Dr. Ezekiel Emanuel, Vice Provost for Global Initiatives & Co-Director of the Health Transformation Institute, University of Pennsylvania
  • Donna Cryer, founder & CEO, Global Liver Institute

Susan Dentzer, Senior Policy Fellow, Duke University’s Robert J. Margolis Center for Health Policy; President & CEO, America’s Physicians Group 

Meeting / Event Tags: 
Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Experts say policymakers must learn from the impact of COVID-19 on older people

In the period between March and December 2020, twice as many years of life were lost in the poorest areas of the country compared with the wealthiest. Ethnic inequalities were a feature across all waves of the pandemic, with rates of death highest among the Bangladeshi and Pakistani communities.

...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Bivalent COVID vaccine protects against death for at least 6 months in older adults, CDC study suggests

The bivalent (two-strain) COVID-19 booster provides substantial protection against death among US adults aged 65 years and older, with no significant signs of waning for up to 6 months, concludes a study published Friday in Morbidity and Mortality Weekly.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

howdy folks
Page loaded in 0.791 seconds.